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SUMMARY
In February 2007 an outbreak of Nipah virus (NiV) encephalitis in Thakurgaon District of
northwest Bangladesh affected seven people, three of whom died. All subsequent cases developed
illness 7–14 days after close physical contact with the index case while he was ill. Cases were more
likely than controls to have been in the same room (100% vs. 9.5%, OR undefined, P<0.001)
and to have touched him (83% vs. 0%, OR undefined, P<0.001). Although the source
of infection for the index case was not identified, 50% of Pteropus bats sampled from near the
outbreak area 1 month after the outbreak had antibodies to NiV confirming the presence
of the virus in the area. The outbreak was spread by person-to-person transmission. Risk
of NiV infection in family caregivers highlights the need for infection control practices to limit
transmission of potentially infectious body secretions.
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INTRODUCTION
In Bangladesh, Nipah virus (NiV) was first identified
as the cause of an outbreak of encephalitis in 2001
in Meherpur District [1, 2]. Four additional out-
breaks were identified between 2001 and 2005 [1–4].
Antibodies reactive to NiV antigen have been de-
tected in pteropid bats in both India and Bangladesh
[1, 5].
Person-to-person transmission of NiV infection,
following human infection directly from the environ-
ment, was noted in previous outbreaks in the Indian
subcontinent. In a NiV outbreak in Siliguri, India
in 2001, 45 patients (75%) had a history of hospital
exposure to other patients with NiV infection [6].
In Faridpur District, Bangladesh in 2004 NiV case-
patients in Faridpur were seven times more likely than
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non-patients to have had close contact with one of the
NiV patients [odds ratio (OR) 6.7, 95% confidence
interval (CI) 2.9–16.8, P<0.001] [2].
On 9 February 2007, a physician at Rangpur Medi-
cal College Hospital, one of 10 hospitals involved in
active NiV encephalitis surveillance in Bangladesh,
reported a cluster of fatal encephalitis involving a
husband and a wife residing in the Haripur Upazila
(subdistrict) of Thakurgaon District. Both patients
had similar symptoms and died within an interval
of 2 weeks. A collaborative team including the Insti-
tute of Epidemiology Disease Control and Research
(IEDCR) and the International Centre for Diarrhoeal
Disease Research, Bangladesh (ICDDR,B), began an
investigation on 10 February 2007. The objectives
of the investigation were to identify the cause of the
outbreak and the risk factors for developing illness.
METHODS
Case definition and identification
We defined suspected case-patients as persons having
fever with altered mental status or new onset of
seizures (severe illness), or persons having fever with
headache or cough (mild illness), residing in the out-
break area with an onset of illness between 15 January
and 28 February 2007. The team visited the outbreak
village and asked the community health workers and
community residents if they were aware of any patient
who was suffering from fever with seizure or altered
mental status, or who had died from these symptoms
in their neighbourhood. We also asked them about
case-patients suffering from fever with headache and/
or cough. The team then visited the local hospital
in order to identify suspected case-patients. Team
members also investigated all the deaths in the out-
break village between January and February. We ob-
tained a history of illness and general information
about exposures for each suspected case-patient. We
asked the local health authority of the affected sub-
district to report to the IEDCR if they identified
any further suspected case-patient having fever and
altered mental status or seizures who sought treat-
ment in the local subdistrict health complex during
February.
The team collected blood samples from living sus-
pected case-patients, which were centrifuged in the
field and transported on wet ice to IEDCR, where
they were stored at x70x. Samples were tested with
an immunoglobulin M (IgM) capture enzyme-linked
immunosorbent assay (ELISA) that detects IgM
antibodies specific for NiV antigens [7].
We defined a confirmed case of NiV infection as a
suspected case-patient with detectable IgM to NiV.
The team defined a probable NiV case-patient as a
patient with fever and altered mental status who lived
in the same village as a confirmed case-patient during
the outbreak period, but from whom serum was not
available because the patient died before a specimen
could be collected.
Qualitative study
A team of experienced anthropologists conducted
in-depth interviews and informal discussions with
available confirmed and probable case-patients, their
family members and friends, and other residents in
these communities with the goals of exploring poten-
tial exposures to NiV and identifying appropriate
proxy respondents for deceased cases or cases that
were too sick to interview. The anthropologists also
collected information about symptoms of the disease,
caregiving practices and health facility utilization by
persons affected by the outbreak.
Case-control study
We conducted a case-control study to investigate
exposures associated with NiV infection, including
person-to-person transmission. Probable and con-
firmed case-patients were enrolled as cases. We selec-
ted three controls for each case-patient. Controls
were selected starting from the fourth closest house to
the case-patient where no members were ill during
the outbreak. The household resident closest in age
to the case-patient was eligible to participate as a
control. Participation was voluntary. If the selected
household resident declined to participate, a resident
from the next closest house was asked to participate.
The qualitative team selected proxy respondents
for each case-patient who had died or was unable to
respond. The proxy respondents included family
members and friends of the case-patients who were
most knowledgeable about their activities and prob-
able risk exposures in the preceding 1 month before
illness. Multiple proxy respondents were common.
The investigation team used a standardized question-
naire to collect information on demographics, symp-
toms of illness, and possible risk factors associated
with NiV transmission including history of con-
sumption of date palm juice prior to illness, exposure
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to animals and exposure to ill patients, including
touching, staying in the same room, feeding, sharing a
bed or cleaning body secretions of a NiV patient.
Bat survey
A team of veterinarians from ICDDR,B with assist-
ance from the Consortium for Conservation Medicine
located two bat roosts which were 1 km and 15 km
distant from the outbreak village. Bats were captured
using mist nets and were anaesthetized during sample
collection and released at the point of capture after
sampling from 24 February to 9 March 2007. All
the captured bats from which blood samples were
collected were P. giganteus.
All bat blood samples were kept on ice until the
end of each day when serum was separated and stored
in liquid nitrogen. At the end of each day, blood
samples were transferred to liquid nitrogen and
transported to ICDDR,B where they were stored at
x70 xC and then shipped on dry ice to the Australian
Animal Health Laboratory for laboratory diagnosis.
All the blood samples were assayed for antibodies
against NiV using a serum neutralization test.
Statistics
We analysed socio-demographic and clinical profiles
of the case-patients using descriptive statistics. For
the case-control study, we used ORs to estimate the
association of each exposure with disease and calcu-
lated 95% CIs around the ORs. We used the x2 test
when expected cell sizes were >5 and Fisher’s exact
test when expected cell sizes were<5 and considered
association to be statistically significant if the P value
was <0.05. We used an unmatched analysis because
neighbours were chosen as controls to ensure that
controls and case-patients were representative of the
same population and not to control for confounding
factors. Because the primary hypothesis was that the
index case was the source of NiV transmission for
the subsequent cases, we excluded the index case, but
none of the controls in the analyses of person-to-
person transmission.
Ethics
All human study participants gave informed consent
for participation in this investigation. The Ethical
Review Committee at ICDDR,B reviewed and ap-
proved a protocol for encephalitis surveillance and
outbreak investigation. Bat capture and sample col-
lection was conducted under a protocol approved by
the Institutional Animal Care and Use Committee.
RESULTS
Descriptive epidemiology
Eleven serum samples were collected from 13 sus-
pected case-patients. Five suspected case-patients
had IgM antibodies against NiV by capture ELISA
and were thus confirmed cases. Two suspected case-
patients had fever and altered mental status, but died
before samples could be collected and were categor-
ized as probable cases. These two probable cases were
the index case and his wife. The remainder of the
analysis was performed on these seven confirmed or
probable case-patients. Five of these case-patients
(three confirmed and two probable) had fever with
altered mental status and three (60%) of them died.
A total of five case-patients, including the two prob-
able cases, were hospitalized. The mean age of case-
patients was 24 years (range 19–30 years) and five
(71%) were male. The median duration from onset
of fever to death was 5.6 days (range 5–7) (Table 1).
Fever (100%), altered consciousness (71%) along
with vomiting (71%) and cough (71%) were the most
common symptoms (Table 1).
Qualitative findings
The index case first developed fever on 21 January
2007 which progressed to headache, cough, breathing
difficulties, convulsions, loss of consciousness and
finally death 5 days later. In total 14 people who were
family members, relatives or friends had physical
contact with the index case when he was ill ; six (43%)
of them developed NiV infection. Five of the sub-
sequent cases had contact with the index case only
during the last 2 days of his illness (incubation period
7–14 days). The dates of illness onset for subsequent
cases ranged from 2 to 8 February 2007 (Fig. 1). None
of the caregivers of the subsequent cases developed
illness.
During the first 4 days of illness the index case was
cared for at home, primarily by his wife and sister-
in-law. They fed him, cleaned him and wiped froth
and saliva from his mouth. They also massaged oil on
his head and body to relieve him of pain. His wife
shared the same bed with him and provided care
throughout his illness. She became severely ill 14 days
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after the husband’s illness began and died within
6 days of illness.
A day before his death, the index case developed a
severe cough and breathing difficulty. He was taken
to a local doctor accompanied by a friend and a
cousin. A chest radiograph of the index case taken
during this period showed diffuse bilateral opacity in
both lung fields suggesting features of acute respirat-
ory distress syndrome (Fig. 2). The friend became ill
11 days later and died after 7 days. The cousin also
became ill 14 days after his physical contact with the
index case.
The day after his chest radiograph, the index case
developed reduced level of consciousness, and was
admitted to a hospital where he died on the same day.
The driver of a micro bus who helped transport and
carry him to the hospital developed NiV infection
10 days after exposure.
While the index case was hospitalized, his wife’s
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Fig. 1. Distribution of NiV cases by date of onset of illness, Haripur Upazila (subdistrict), Thakurgaon District, Bangladesh,
January–February 2007.%, Alive ;&, died.
Table 1. Characteristics of case-patients, Haripur


















Respiratory distress 4 (57)
Altered mental status 5 (71)
Muscle pain 4 (57)
Restlessness 4 (57)
Unconscious 2 (29)
Joint pain 1 (14)
Case fatality 3 (43)
Onset of illness to death (n=3),
mean (range)
5.6 (5–7)
Fig. 2. Chest X-ray of the index case showing features of
acute respiratory distress syndrome.
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and fed and touched him. Both of them developed
NiV infection within 10 days of contact.
Case-control study
We used proxy interviews for the three dead case-
patients, but not for any controls. The mean age
for cases and controls was similar [mean age (¡S.D.)
24¡4 years in cases vs. 24¡7 years in controls,
t=x0.097, P=0.9]. Cases were more likely to be
males than controls but this could be due to chance
(67% males in case-patient group vs. 38% in control
group, OR 3.2, 95% CI 0.5–22, P=0.2).
NiV case-patients were more likely than controls
to have consumed raw date palm sap in the 15 days
prior to illness (29% in case-patients vs. 0% in con-
trols, OR undefined, P=0.056). Two (29%) of the
case-patients including the index case who had con-
sumed raw date palm juice bought it from a vendor
in the local village market. Although there were
sick goats in the outbreak-affected community, none
of the cases or controls had any contact with them or
any other sick animal within 15 days prior to illness.
Moreover, there was no report of contact with fruit
bats.
In the analysis for person-to-person transmission,
case-patients were more likely than controls to have
been present in the same room with (100% vs. 9.5%,
OR undefined, P=0.000) or touched (83% vs. 0%,
OR undefined, P=0.000) the index case. In a sub-
analysis in those who stayed in the same room with
the index case, case-patients were more likely than
controls to be present in the same room when he was
coughing (100% vs. 0%, OR undefined, P=0.04).
Only case-patients had hospital exposure to other
NiV case-patients (86% vs. 0%, P=0.000), with
all reporting visits to the index case in the hospital
(Table 2).
Bat study
The team captured and sampled 118 P. giganteus
bats ; 29 of which were juvenile bats. Of the 67 bats
sampled 1 km from the outbreak village, 34 (51%)
tested positive on serum neutralization test [median
titre 30, range 5 to >640]. Three of the 34 serum
neutralization test-positive bats had NiV antibody
titres>640. In the neighbouring village, 15 km away,
27/51 bats (53%) had serum neutralizing antibodies
to NiV [median titre 20, range 5–320]. Of the 61
pteropid bats that were seropositive seven were
juvenile bats [median titre 15, range 5–20].
DISCUSSION
Several lines of evidence suggest person-to-person
transmission as the primary route of transmission in
this outbreak. The epidemic curve showing a gap of








this risk factor OR 95% CI P value
Male sex 4 (67%) 8 (38%) 3.25 0.48–22 0.2
Climbed trees 1 (17) 4 (19%) 0.85 0.07–9.4 1.00
Physical contact with living animal
Pig 0 (0%) 0 (%) Undefined
Fruit bat 0 (0%) 0 (0%) Undefined
Cow 4 (67%) 13 (62%) 1.23 0.182–8.33 1.00
Goat 2 (33%) 9 (43%) 0.67 0.099–4.5 1.00
Ate any animal that had been sick 0 (0%) 1 (5%) Undefined 1.00
Drank raw date palm sap 1 (17%) 0 (0%) Undefined 0.22
Visited the index case in a hospital 6 (100%) 0 (0%) Undefined <0.001
Touched the index case when he was sick 5 (83.3%) 0 (0%) Undefined <0.001
Been present in the same room with the index
case when he was sick
6 (100%) 2 (9.5%) Undefined <0.001
Been present in the same room with the index
case when he was coughing
6 (100%) 0 (0%) Undefined 0.04
OR, Odds ratio ; CI, confidence interval.
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12–18 days between the single primary case and the
secondary cases corresponds with the incubation
period of human NiV infection [8]. Many of the index
case’s contacts (43%), who came in physical contact
with the index case when he was ill, subsequently
became ill. In the case-control study, case-patients
were significantly more likely to be in contact with the
index case and were significantly more likely to be
near him when he was coughing. As subsequent cases
were limited to close contacts of the primary case, and
none of the contacts of the subsequent cases devel-
oped illness, we conclude that the index case was the
only NiV transmitter in this outbreak.
Five (83%) of the subsequent cases came in contact
with the index case only during the last 2 days of his
illness when he developed respiratory symptoms. NiV
has been isolated from human saliva, urine, nasal and
pharyngeal secretions [9, 10] and there is evidence
of spread of NiV infection from direct contact with
respiratory secretions or other body secretions of in-
fected pigs and humans [2, 11, 12]. The probability
of NiV transmission is probably amplified during
the last stages of illness when respiratory symptoms
become more prominent and perhaps the concen-
tration of virus in respiratory secretions increases. In
Bangladesh, as the level of physical contact with the
patient intensifies with the severity of the disease [13],
this further increases the risk of transmission.
The NiV neutralizing antibody prevalence was
>50% in the bats sampled from the outbreak area
which suggests that NiV has circulated in this popu-
lation of bats. The result is consistent with findings
in other pteropid bat populations in Malaysia, India,
and Bangladesh [1, 5, 14, 15]. The bat survey was
performed approximately 1 month after the onset of
illness in the index case, and it is possible that infected
bats were present in the colony around the time of the
first human infection. Furthermore, the index case
had no evidence of exposure to clinically ill domestic
animals. He also had history of drinking raw date
palm juice before his illness which has been associated
with NiV infection in a previous outbreak inves-
tigation [3]. These lines of evidence suggest that the
virus was probably transmitted directly from its
natural reservoir, rather than an intermediate dom-
estic animal.
A limitation of our study is its reliance on proxy
interviews for some of the case-patients. This may
have obscured some exposure information. However,
we started our investigation within 14 days of the
death of the index case, and collected information
from several proxy respondents thus reducing the
likelihood that we failed to collect information on
probable exposure to risk factors. Another limitation
is the lack of serological data from controls. There
is evidence of subclinical infection of NiV from
Malaysia [16] which could have reduced power to
identify association due to erroneous inclusion of
cases as controls. Even with this potential limitation
our results identified a biologically credible pathway
for transmission.
Findings from outbreaks in Siliguri and Faridpur
illustrate that human-to-human transmission has
occurred repeatedly in the Indian subcontinent. The
social norm in Bangladesh is that family members
and loved ones provide hands-on care to sick
patients [13]. Further, hospital healthcare workers in
Bangladesh are reluctant to provide hands-on care to
admitted patients which increases the risk of trans-
mission to family members and relatives who provide
care without any training or supplies to reduce the
risk of transmission [13]. Efforts to educate care-
givers of their risk especially at later stages of illness,
while maintaining sensitivity to cultural mores, and
promoting basic infection control practices such as
washing hands with soap after handling patients and
avoiding close physical contact [2] could limit trans-
mission of NiV and other diseases in people who care
for sick patients.
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